Waters Corporation Stock London S.E.

Equities

0LTI

US9418481035

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 10:24:06 2024-05-23 am EDT 5-day change 1st Jan Change
344.1 USD -2.36% Intraday chart for Waters Corporation -2.17% +7.35%
Sales 2024 * 2.97B Sales 2025 * 3.15B Capitalization 20.69B
Net income 2024 * 637M Net income 2025 * 719M EV / Sales 2024 * 7.42 x
Net Debt 2024 * 1.31B Net Debt 2025 * 1.1B EV / Sales 2025 * 6.92 x
P/E ratio 2024 *
32.3 x
P/E ratio 2025 *
28.4 x
Employees 7,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.46%
1 week-2.17%
Current month+13.78%
1 month+17.28%
3 months+7.05%
6 months+27.57%
Current year+7.35%
More quotes
1 week
349.57
Extreme 349.57
362.55
1 month
303.49
Extreme 303.4927
368.16
Current year
292.92
Extreme 292.92
368.16
1 year
232.01
Extreme 232.01
368.16
3 years
232.01
Extreme 232.01
425.84
5 years
164.20
Extreme 164.2
425.84
10 years
164.20
Extreme 164.2
425.84
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 20-08-31
Director of Finance/CFO 48 21-05-11
Chief Operating Officer - 21-12-31
Members of the board TitleAgeSince
Director/Board Member 65 18-08-31
Director/Board Member 68 23-03-26
Director/Board Member 70 06-04-30
More insiders
Date Price Change Volume
24-05-22 352.5 -0.74% 25
24-05-21 352 -1.13% 114
24-05-20 356 -0.79% 59
24-05-17 358.9 -1.13% 11
24-05-16 363 +0.75% 35

Delayed Quote London S.E., May 22, 2024 at 10:14 am EDT

More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
348.8 USD
Average target price
326 USD
Spread / Average Target
-6.53%
Consensus